Advertisement

World Journal of Surgery

, Volume 34, Issue 4, pp 776–783 | Cite as

Validating a Simple Scoring System to Predict Malignancy and Invasiveness of Intraductal Papillary Mucinous Neoplasms of the Pancreas

  • Sang H. Shin
  • Duck J. Han
  • Kwan T. Park
  • Young H. Kim
  • Jae B. Park
  • Song C. Kim
Article

Abstract

Background

The objective of the present study was to identify reliable preoperative factors predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm (IPMN) of the pancreas and the effectiveness of a diagnostic scoring system based on these factors.

Methods

Between August 1994 and December 2007, 204 patients underwent pancreatic resection for IPMN at a single institute. Medical records were reviewed retrospectively, and a new diagnostic scoring system for predicting malignant IPMN preoperatively was designed.

Results

Univariate analysis revealed nine significant predictors of both malignant and invasive IPMN: age ≥60 years, history of pancreatitis, presence of mural nodule(s), diameter of main pancreatic duct (MPD) >6 mm, main duct or mixed type, total bilirubin >1.2 mg/dl, CA-19-9 >37 U/ml, tumor location in the pancreatic head, and tumor size >30 mm. Multivariate analysis showed that age, pancreatitis, mural nodule(s), and MPD diameter were independent predictors of invasive IPMN, and that all these parameters, plus elevated carbohydrate antigen-19-9 (CA-19-9), were independent predictors of malignant IPMN. A scoring system based on these five factors, each assigned 1 point, and with a cut-off of 3 points, could predict malignant IPMN with a sensitivity of 50.7% and a specificity of 90.1%. The 5-year survival rates of patients with benign and malignant IPMN were 95.0% and 64.0%, respectively.

Conclusions

Our scoring system using five independent factors (age ≥60 years, history of pancreatitis, presence of mural nodule(s), elevated level of CA-19-9, and MPD diameter >6 mm) may be helpful for predicting malignancy and postoperative survival.

Keywords

Pancreatitis Receiver Operating Characteristic Intraductal Papillary Mucinous Neoplasm Mural Nodule Diagnostic Score 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Ohhashi K, Murakami Y, Maruyama M et al (1982) Four cases of mucin producing cancer of the pancreas on specific findings of the papilla of Vater. Prog Dig Endosc 20:348–351Google Scholar
  2. 2.
    Klöppel G, Solcia E, Longnecker DS et al (1996) Histological typing of tumors of the exocrine pancreas. In: World Health Organization international histologic classification of tumors, 2nd edn. Springer-Verlag, BerlinGoogle Scholar
  3. 3.
    Wilentz RE, Iacobuzio-Donahue CA, Argani P et al (2000) Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res 60:2002–2006PubMedGoogle Scholar
  4. 4.
    Hruban RH, Adsay NV, Albores-Saavedra J et al (2001) Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 25:579–586CrossRefPubMedGoogle Scholar
  5. 5.
    Tanaka M, Chari S, Adsay V et al (2006) International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 6:17–32CrossRefPubMedGoogle Scholar
  6. 6.
    Nakagohri T, Kenmochi T, Kainuma O et al (2000) Inferior head resection of the pancreas for intraductal papillary mucinous tumors. Am J Surg 179:482–484CrossRefPubMedGoogle Scholar
  7. 7.
    Murakami Y, Uemura K, Yokoyama Y et al (2004) Pancreatic head resection with segmental duodenectomy for intraductal papillary mucinous tumors of the pancreas. J Gastrointest Surg 8:713–719CrossRefPubMedGoogle Scholar
  8. 8.
    Solcia E, Capella C, Kloppel G (1997) Armed Forces Institute of Pathology. In: Atlas of tumor pathology: tumors of the pancreas, 3rd edn. American Registry of Pathology in collaboration with Armed Forces Institute of Pathology, Washington, DCGoogle Scholar
  9. 9.
    Sugiyama M, Izumisato Y, Abe N et al (2003) Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas. Br J Surg 90:1244–1249CrossRefPubMedGoogle Scholar
  10. 10.
    Wiesenauer CA, Schmidt CM, Cummings OW et al (2003) Preoperative predictors of malignancy in pancreatic intraductal papillary mucinous neoplasms. Arch Surg 138:610–617CrossRefPubMedGoogle Scholar
  11. 11.
    Salvia R, Fernandez-del Castillo C, Bassi C et al (2004) Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 239:678–685CrossRefPubMedGoogle Scholar
  12. 12.
    Sohn TA, Yeo CJ, Cameron JL et al (2004) Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 239:788–797; discussion 797–789CrossRefPubMedGoogle Scholar
  13. 13.
    Murakami Y, Uemura K, Hayashidani Y et al (2007) Predictive factors of malignant or invasive intraductal papillary-mucinous neoplasms of the pancreas. J Gastrointest Surg 11:338–344CrossRefPubMedGoogle Scholar
  14. 14.
    Bassi C, Sarr MG, Lillemoe KD et al (2008) Natural history of intraductal papillary mucinous neoplasms (IPMN): current evidence and implications for management. J Gastrointest Surg 12:645–650CrossRefPubMedGoogle Scholar
  15. 15.
    Kim SC, Park KT, Lee YJ et al (2008) Intraductal papillary mucinous neoplasm of the pancreas: clinical characteristics and treatment outcomes of 118 consecutive patients from a single center. J Hepatobiliary Pancreat Surg 15:183–188CrossRefPubMedGoogle Scholar
  16. 16.
    Nagai K, Doi R, Kida A et al (2008) Intraductal papillary mucinous neoplasms of the pancreas: clinicopathologic characteristics and long-term follow-up after resection. World J Surg 32:271–278CrossRefPubMedGoogle Scholar
  17. 17.
    Nara S, Onaya H, Hiraoka N et al (2008) Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases. Pancreas 38:8–16CrossRefGoogle Scholar
  18. 18.
    Sugiyama Matomi Y (1998) Intraductal papillary mucinous tumors of the pancreas: imaging studies and treatment strategies. Ann Surg 228:685–691CrossRefGoogle Scholar
  19. 19.
    Falconi M, Salvia R, Bassi C et al (2001) Clinicopathological features and treatment of intraductal papillary mucinous tumour of the pancreas. Br J Surg 88:376–381CrossRefPubMedGoogle Scholar
  20. 20.
    Kanazumi N, Nakao A, Kaneko T et al (2001) Surgical treatment of intraductal papillary-mucinous tumors of the pancreas. Hepatogastroenterology 48:967–971PubMedGoogle Scholar
  21. 21.
    Chari ST, Yadav D, Smyrk TC et al (2002) Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology 123:1500–1507CrossRefPubMedGoogle Scholar
  22. 22.
    Nakagohri T, Asano T, Kenmochi T et al (2002) Long-term surgical outcome of noninvasive and minimally invasive intraductal papillary mucinous adenocarcinoma of the pancreas. World J Surg 26:1166–1169CrossRefPubMedGoogle Scholar
  23. 23.
    Raimondo M, Tachibana I, Urrutia R et al (2002) Invasive cancer and survival of intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol 97:2553–2558CrossRefPubMedGoogle Scholar
  24. 24.
    Niedergethmann M, Grutzmann R, Hildenbrand R et al (2008) Outcome of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas (IPMN): a 10-year experience. World J Surg 32:2253–2260CrossRefPubMedGoogle Scholar
  25. 25.
    Sohn TA, Yeo CJ, Cameron JL et al (2001) Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity. Ann Surg 234:313–321CrossRefPubMedGoogle Scholar
  26. 26.
    Maire F, Hammel P, Terris B et al (2002) Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Gut 51:717–722CrossRefPubMedGoogle Scholar
  27. 27.
    Shimada K, Sakamoto Y, Sano T et al (2006) Invasive carcinoma originating in an intraductal papillary mucinous neoplasm of the pancreas: a clinicopathologic comparison with a common type of invasive ductal carcinoma. Pancreas 32:281–287CrossRefPubMedGoogle Scholar
  28. 28.
    Woo SM, Ryu JK, Lee SH et al (2008) Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma. Pancreas 36:50–55CrossRefPubMedGoogle Scholar
  29. 29.
    Murakami Y, Uemura K, Sudo T et al (2009) Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma. J Surg Oncol 100:13–18CrossRefPubMedGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2010

Authors and Affiliations

  • Sang H. Shin
    • 1
  • Duck J. Han
    • 1
  • Kwan T. Park
    • 2
  • Young H. Kim
    • 1
  • Jae B. Park
    • 1
  • Song C. Kim
    • 1
  1. 1.Department of SurgeryUniversity of Ulsan College of Medicine and Asan Medical CenterSeoulKorea
  2. 2.Department of SurgeryKorea University Medical CenterSeoulKorea

Personalised recommendations